These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 19902267

  • 1. Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
    Tanaka Y, Yoshikawa N, Hattori S, Sasaki S, Ando T, Ikeda M, Honda M, Japanese Study Group for Renal Disease in Children.
    Pediatr Nephrol; 2010 May; 25(5):877-82. PubMed ID: 19902267
    [Abstract] [Full Text] [Related]

  • 2. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
    Miyamae T, Nakasima S, Imagawa T, Ito S, Katakura S, Tomono N, Mori M, Ibe M, Mitsuda T, Aihara Y, Yokota S.
    Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of steroid pulse therapy in combination with mizoribine following tonsillectomy for immunoglobulin A nephropathy in renally impaired patients.
    Kaneko T, Shimizu A, Tsuruoka S, Iino Y, Katayama Y.
    J Nippon Med Sch; 2013 Dec; 80(4):279-86. PubMed ID: 23995570
    [Abstract] [Full Text] [Related]

  • 4. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Tanaka H, Tsugawa K, Oki E, Suzuki K, Ito E.
    Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
    [Abstract] [Full Text] [Related]

  • 5. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H, Hiromasa T, Hara T, Takaki A, Yamanaka R, Sada KE, Makino H.
    Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
    [Abstract] [Full Text] [Related]

  • 6. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
    Fujieda M, Ishihara M, Morita T, Hayashi A, Okada S, Ohta T, Sakano T, Wakiguchi H.
    Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
    [Abstract] [Full Text] [Related]

  • 7. [Effects of combined administration of prednisolone and mizoribine in the course of remission for SLE children with nephritis].
    Aihara Y, Ibe M, Mitsuda T, Mori M, Shimizu C, Takahashi Y, Kuriyama T, Yokota S.
    Ryumachi; 1994 Feb; 34(1):64-70. PubMed ID: 8146731
    [Abstract] [Full Text] [Related]

  • 8. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Igarashi T, Igarashi T, Shimizu A, Itoh Y.
    J Nippon Med Sch; 2013 Feb; 80(5):396-400. PubMed ID: 24189359
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
    Nomura A, Shimizu H, Kishimoto M, Suyama Y, Rokutanda R, Ohara Y, Yamaguchi K, Okada M.
    Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome.
    Kawasaki Y, Suzuki J, Takahashi A, Isome M, Nozawa R, Suzuki H.
    Pediatr Nephrol; 2005 Jan; 20(1):96-8. PubMed ID: 15503173
    [Abstract] [Full Text] [Related]

  • 12. Mizoribine: a new approach in the treatment of renal disease.
    Kawasaki Y.
    Clin Dev Immunol; 2009 Jan; 2009():681482. PubMed ID: 20052390
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.
    Mima A.
    Rheumatol Int; 2017 Aug; 37(8):1387-1393. PubMed ID: 28255645
    [Abstract] [Full Text] [Related]

  • 14. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
    Kaneko T, Arai M, Ikeda M, Morita M, Watanabe Y, Hirama A, Shimizu A, Tsuruoka S.
    Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
    [Abstract] [Full Text] [Related]

  • 15. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S, Kaneko K, Ohtomo Y, Murakami H, Takada M, Akashi S, Hira M, Yamashiro Y.
    Pediatr Nephrol; 2005 Oct; 20(10):1500-3. PubMed ID: 16021476
    [Abstract] [Full Text] [Related]

  • 16. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.
    Kawasaki Y, Hosoya M, Suzuki J, Onishi N, Takahashi A, Isome M, Nozawa R, Suzuki H.
    Am J Nephrol; 2004 Jul; 24(6):576-81. PubMed ID: 15550753
    [Abstract] [Full Text] [Related]

  • 18. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 19. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
    Ishida H, Takahara S, Amada N, Tomikawa S, Chikaraishi T, Takahashi K, Uchida K, Akiyama T, Tanabe K, Toma H, Study Group for the Antimetabolite Comparison of Trial (AMCT).
    Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
    Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.